ARCHIVES

In Brief: City of Hope launches Hematologic Malignancies and Stem Cell Transplantation Institute

This article is from The Cancer Letter archive.

Vol. 40 No. 41 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial

May 30, 2014

Cancer Groups Propose Six Characteristics Of Next FDA Head.

December 19, 2008

Data Falsification Charge To Be Aired

June 27, 1980

Amgen Agrees to Settle Aranesp Marketing Lawsuit, Reserves $780 Million For Settlement

October 28, 2011

Self-Collected Pap Smear Tests Could Advance HPV Screening

January 27, 2012

New Trial For Metastatic Colorectal Cancer Testing Vaccine-Chemotherapy Combination

March 29, 2002